Narcolepsy Market Size & Share | Industry Analysis 2021-2027
The narcolepsy market size is estimated to reach US$ 4,537.9 million by 2027 from US$ 2,026.8 million in 2018; it is estimated to grow at a CAGR of 9.5% during 2019-2027.
Narcolepsy is a rare long-term brain disorder characterized by excessive sleepiness, sleep paralysis, hallucinations, and episodes of cataplexy among certain patients. Narcolepsy is known to occur equally among men and women, and the global incidence of narcolepsy is estimated to be roughly 1 in 2,000 people. People with narcolepsy feel very sleepy during the day and may involuntarily fall asleep during normal activities. Furthermore, narcolepsy is characterized by excessive drowsiness and sleep episodes. Narcolepsy makes it difficult for people to stay awake for lengthy periods of time and makes them sleepy for most of the day.
The narcolepsy market growth is attributed to the rising prevalence of sleep-related neurological disorders, emerging local pharmaceutical and biopharmaceutical companies, and increasing awareness regarding neurological disorders. However, side effects and risks associated with the narcolepsy medications and delayed diagnosis and misdiagnosis of the disease are likely to pose a negative impact on the narcolepsy market growth.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Narcolepsy Market: Strategic Insights
Market Size Value in US$ 2,026.8 Million in 2018 Market Size Value by US$ 4,537.9 Million by 2027 Growth rate CAGR of 9.5% from 2019 to 2027 Forecast Period 2019-2027 Base Year 2018
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Narcolepsy Market: Strategic Insights
| Market Size Value in | US$ 2,026.8 Million in 2018 |
| Market Size Value by | US$ 4,537.9 Million by 2027 |
| Growth rate | CAGR of 9.5% from 2019 to 2027 |
| Forecast Period | 2019-2027 |
| Base Year | 2018 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Market Insights
Rising Prevalence of Sleep-Related Neurological Disorders Drives Narcolepsy Market
Rising Prevalence of Sleep-Related Neurological Disorders Drives Narcolepsy Market
The range of sleep disorders that are treated by neurologists is wide and includes conditions such as insomnia, sleep apnea, restless legs syndrome, and narcolepsy. These disorders cause disruptions in the normal sleep–wake mechanisms causing endogenous abnormalities. Neurological sleep-related disorders are expected to increase in the coming years, as a large portion of the population will enter old age. According to the National Institute of Health (NIH), approximately 40 million Americans suffer from neurological diseases in the US and 20 million people experience occasional sleeping problems.
Over the last decades, much has been learned about the pathophysiology of narcolepsy. According to the National Center for Biotechnology Information, the prevalence of narcolepsy with cataplexy has been examined in many studies and falls between 25 and 50 per 100,000 people. Moreover, according to the Narcolepsy Network 2017, the condition affects 1 in every 2,000 people in the US, i.e., 200,000 Americans and approximately 3 million worldwide. Moreover, the American Sleep Apnea Association reports that sleep-related problems affect 50–70 million Americans of all ages and socioeconomic classes. However, important disparities in the prevalence and severity of certain sleep disorders have been identified in minorities and underserved populations. More than 50 million Americans already suffer from over 80 different sleep disorders and another 20–30 million suffer from intermittent sleep problems each year.
People with narcolepsy suffer from chronic daytime sleepiness and episodes in which they fall asleep unexpectedly during the day. These "sleep attacks" can occur at any time, during any activity. Sleep attacks are not limited to periods of dull or low engagement activities, but can happen during school or work hours, in the middle of a conversation, while eating, while exercising or playing sports, or even while driving. Thus, the surge in the prevalence of sleep-related neurological disorders is likely to propel the narcolepsy market’s trends forward during the forecast period.
Type-Based Insights
The global narcolepsy market, based on type, is segmented into narcolepsy with cataplexy, narcolepsy without cataplexy, and secondary narcolepsy. The narcolepsy with cataplexy segment held the largest share among the type subsegments in the narcolepsy market in 2018 and is also anticipated to witness a similar trend over the forecast period. Narcolepsy with cataplexy also referred to as Narcolepsy Type-1 is a rare neurological disorder that is diagnosed based on having low levels of a brain hormone (hypocretin) or reported events of cataplexy within an individual. Cataplexy refers to sudden and uncontrollable muscle weakness or paralysis that majorly occurs in a day and is often triggered by strong emotions, such as excitement or laughter. The person loses muscle tone and can have a slack jaw, broken speech, buckled knees, or total weakness in their face, arms, legs, and trunk, without much of a warning. The loss of muscle tone in cataplexy occurs because of the inability to regulate sleep and awake states. In about 10% of cases of narcolepsy, cataplexy is the first symptom to appear and can be misdiagnosed as a seizure disorder.
Product-Based Insights
The global narcolepsy market, based on product, is segmented into central nervous system (CNS) stimulants, sodium oxybate, and antidepressants. The sodium oxybate segment held the largest narcolepsy market share in 2018. Sodium oxybate is also known as gamma-hydroxybutyrate (GHB) is known to reduce daytime sleepiness and cataplexy by improving nighttime sleep in patients with narcolepsy. GHB is used to treat narcolepsy, a condition that causes severe daytime sleepiness. Sodium oxybate can decrease daytime sleepiness and also reduce the number of sudden short attacks of weak/paralyzed muscles (known as cataplexy) that can occur in patients with narcolepsy. This medication is highly effective for cataplexy. Sodium oxybate helps improve nighttime sleep, which is often poor in narcolepsy. In high doses, it may also help control daytime sleepiness. It must be taken in two doses, one at bedtime and one up to four hours later.
Distribution Channel-Based Insights
The global narcolepsy market, based on distribution channel, is divided into hospital pharmacies and retail pharmacies. The hospital pharmacies segment led the narcolepsy market in 2018. Hospital pharmacies refers to the medical pharmacies situated usually in the hospital premises. These pharmacies stock a large number of medications that majorly include specialized and investigational medications. Hospital pharmacies typically provide medications for hospitalized patients only and are not retail establishments. Hospital pharmacies may provide a huge quantity of medications per day allocated to the wards and intensive care units according to a patient's medication schedule. Larger hospitals may use automated transport systems to aid in the efficient distribution of medications.
Narcolepsy Market Report Scope
Product launches and approvals are commonly adopted strategies by companies to expand their global footprints and product portfolios. Moreover, the players focus on the partnership strategy to enlarge their clientele, which, in turn, permits them to maintain their brand name across the world. The market share is anticipated to flourish with the development of new innovative products by market players. Some of the market participants offering products are Teva Pharmaceutical Industries Ltd; Jazz Pharmaceuticals plc; Arena Pharmaceuticals, Inc; Graymark Healthcare, Inc; Novartis AG; Takeda Pharmaceutical Company Limited; Mylan N.V.; BIOPROJET; Shionogi & Co., Ltd; and Ligand Pharmaceuticals, Inc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, Product Stimulants, Distribution Channel, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
US, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
1. INTRODUCTION
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 market segmentation
1.3.1 Global Narcolepsy Market – By Type
1.3.2 Global Narcolepsy Market – By Product
1.3.3 Global Narcolepsy Market – By Distribution Channel
1.3.4 Global Narcolepsy Market – By Geography
2. Global Narcolepsy market – Key takeaways
3. research Methodology
3.1.1 Coverage
3.1.2 Secondary Research
3.1.3 Primary Research
4. Global narcolepsy market – market landscape
4.1 overview
4.2 pest analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe– PEST Analysis
4.2.3 Asia Pacific– PEST Analysis
4.2.4 Middle East & Africa– PEST Analysis
4.2.5 South and Central America – PEST Analysis
5. Global Narcolepsy market – Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Rising Prevalence of Sleep Related Neurological Disorders
5.1.2 Emerging Local Pharmaceutical and Biopharmaceutical Companies
5.1.3 Increasing Awareness Regarding Neurological Disorders
5.2 Key Market Restraints
5.2.1 Side Effects and Risks Associated with Narcolepsy Medications
5.2.2 Delayed Diagnosis or Misdiagnosis of Narcolepsy
5.3 Key Market Opportunities
5.3.1 Robust Pipeline Drugs for Narcolepsy
5.4 Future Trends
5.4.1 New Treatments for Narcolepsy
5.5 Impact analysis
6. Narcolepsy market – Global Analysis
6.1 global Narcolepsy market Revenue Forecasts and Analysis
6.2 global Narcolepsy market, By Geography - Forecasts and Analysis
6.3 PERFORMANCE OF KEY PLAYERS
6.3.1 Jazz Pharmaceuticals plc
6.3.2 Teva Pharmaceutical Industries Ltd.
6.4 Brand Analaysis
6.4.1 Marketed Drugs:
6.4.2 Provigil
6.4.2.1 Overview:
6.4.2.2 Drug Description:
6.4.2.3 Advantages & Disadvantages:
6.4.3 Xyrem
6.4.3.1 Overview:
6.4.3.2 Drug Description:
6.4.3.3 Advantages & Disadvantages:
6.4.4 Nuvigil
6.4.4.1 Overview:
6.4.4.2 Drug Description:
6.4.4.3 Advantages & Disadvantages:
6.5 Pipeline Analysis
7. Narcolepsy Market Analysis and forecasts to 2027 – type
7.1 Overview
7.2 type market Revenue and Forecasts Analysis (US$ Mn)
7.3 Narcolepsy with cataplexy Market
7.3.1 Overview
7.3.2 Narcolepsy With Cataplexy Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Narcolepsy without cataplexy Market
7.4.1 Overview
7.4.2 Narcolepsy Without Cataplexy Market Revenue and Forecast to 2027 (US$ Mn)
7.5 Secondary Narcolepsy Market
7.5.1 Overview
7.5.2 Secondary Narcolepsy Market Revenue and Forecast to 2027 (US$ Mn)
8. Narcolepsy Market Analysis and forecasts to 2027 – product
8.1 Overview
8.2 product market Revenue and Forecasts Analysis (US$ Mn)
8.3 central nervous system stimulants Market
8.3.1 Overview
8.3.2 Central Nervous System Stimulants Market Revenue and Forecast to 2027 (US$ Mn)
8.4 sodium oxybate Market
8.4.1 Overview
8.4.2 Sodium Oxybate Market Revenue and Forecast to 2027 (US$ Mn)
8.5 Antidepressants Market
8.5.1 Overview
8.5.2 Antidepressants Market Revenue and Forecast to 2027 (US$ Mn)
9. Narcolepsy Market Analysis and forecasts to 2027 – Distribution Channel
9.1 Overview
9.2 Distribution Channel market Revenue and Forecasts Analysis (US$ Mn)
9.3 hospital pharmacies Market
9.3.1 Overview
9.3.2 Hospital Pharmacies Market Revenue and Forecast to 2027 (US$ Mn)
9.4 retail pharmacies Market
9.4.1 Overview
9.4.2 Retail Pharmacies Market Revenue and Forecast to 2027 (US$ Mn)
10. NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027 – GEOGRAPHICAL ANALYSIS
10.1 north america narcolepsy market
10.1.1 Overview
10.1.2 North America Narcolepsy Market Revenue And Forecasts to 2027 (US$ Mn)
10.1.3 North America Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.4 North America Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.1.5 North America Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.1.6 North America Narcolepsy Market Revenue And Forecasts to 2027, By Country (%)
10.1.7 US Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.8 US Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.8.1 US Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.8.2 US Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.1.8.3 US Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.1.9 Canada Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.10 Canada Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.10.1 Canada Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.10.2....... Canada Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.1.10.3....... Canada Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.1.11 Mexico Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.12 Mexico Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.12.1. Mexico Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.1.12.2........ Mexico Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.1.12.3........ Mexico Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.2 Europe narcolepsy market
10.2.1 Overview
10.2.2 Europe Narcolepsy market revenue Overview, by Country (2017) (us$ mn)
10.2.3 Europe Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.4 Europe Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.2.5 Europe Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.2.6 Europe Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.2.7 Europe Narcolepsy market Revenue and Forecasts to 2027, By Country (%)
10.2.8 Germany Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.9 Germany Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.9.1 Germany Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.2.9.2 Germany Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.2.9.3 Germany Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.2.10 UK Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.11 UK Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.11.1 UK Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.2.11.2. UK Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.2.11.3............... UK Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.2.12 France Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.13 France Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.13.1 France Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.2.13.2........ France Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.2.13.3........ France Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.2.14 Italy Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.15 Italy Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.15.1.... Italy Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.2.15.2........... Italy Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.2.15.3........... Italy Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.2.16 Spain Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.17 Spain Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.17.1... Spain Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.2.17.2.......... Spain Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.2.17.3.......... Spain Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.3 ASIA Pacific NARCOLEPSY MARKET
10.3.1 Overview
10.3.2 Asia Pacific Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.3 Asia Pacific Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.3.4 Asia Pacific Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.3.5 Asia Pacific Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.3.6 Asia Pacific Narcolepsy Market Revenue and Forecasts to 2027, By Country (%)
10.3.7 China Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.8 China Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.8.1 China Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.3.8.2 China Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.3.8.3 China Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.3.9 Japan Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.10 Japan Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.10.1... Japan Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.3.10.2.......... Japan Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.3.10.3.......... Japan Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.3.11 India Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.12 India Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.12.1... India Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.3.12.2........... India Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.3.12.3........... India Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.3.13 Australia Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.14 Australia Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.14.1.... Australia Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.3.14.2.... Australia Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.3.14.3.... Australia Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.3.15 South Korea Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.16 South Korea Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.16.1 South Korea Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.3.16.2 South Korea Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.3.16.3 South Korea Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.4 Middle East & Africa Narcolepsy market
10.4.1 Middle East & Africa Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.2 Middle East & Africa Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.4.3 Middle East & Africa Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.4.4 Middle East & Africa Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.4.5 Middle East & Africa Narcolepsy market Revenue and Forecasts to 2027, By Country (%)
10.4.6 UAE Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.7 UAE Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.7.1 UAE Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.4.7.2 UAE Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.4.7.3 UAE Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.4.8 Saudi Arabia Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.9 Saudi Arabia Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.9.1 Saudi Arabia Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.4.9.2 Saudi Arabia Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.4.9.3 Saudi Arabia Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.4.10 South Africa Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.11 South Africa Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.11.1... South Africa Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.4.11.2... South Africa Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.4.11.3... South Africa Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.5 SOUTH AND CENTRAL AMERICA NARCOLEPSY MARKET
10.5.1 Overview
10.5.2 South and Central America Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.5.3 South & Central America Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.5.4 South & Central America Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.5.5 South & Central America Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.5.6 South and Central America Narcolepsy Market Share by Country, 2017 and 2027 (%)
10.5.7 Brazil Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.5.8 Brazil Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.5.8.1 Brazil Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.5.8.2 Brazil Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.5.8.3 Brazil Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
10.5.9 Argentina Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
10.5.10 Argentina Narcolepsy market Revenue and Forecasts to 2027 (US$ Mn)
10.5.10.1... Argentina Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)
10.5.10.2... Argentina Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)
10.5.10.3... Argentina Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
11. Narcolepsy market – Industry Landscape
11.1 Overview
11.2 Comparative Company Analysis
11.3 Growth Strategies in the Narcolepsy market, 2015-2018
11.4 Organic Growth Strategies
11.4.1 Overview
11.4.2 Expansions
11.4.3 Product Launches
11.4.4 Other Organic Growth Strategies
11.5 Inorganic Growth Strategies
11.5.1 Overview
11.5.2 Agreements
11.5.3 Acquisitions
11.5.4 Other Inorganic Growth Strategies
12. Narcolepsy market –Key company profiles
12.1 Teva Pharmaceutical Industries Ltd.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Financial Overview
12.1.4 Product Portfolio
12.1.5 Swot Analysis
12.1.6 Key Developments
12.2 Jazz Pharmaceuticals plc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Financial Overview
12.2.4 Product Portfolio
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Arena Pharmaceuticals, Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Financial Overview
12.3.4 Product Portfolio
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Graymark Healthcare, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Financial Information
12.4.4 Product Portfolio
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Novartis AG
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Financial Information
12.5.4 Product Portfolio
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Takeda Pharmaceutical Company Limited
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Financial Information
12.6.4 Product Pipeline
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Mylan N.V.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Financial Overview
12.7.4 Product Portfolio
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 BIOPROJET
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Financial Overview
12.8.4 Product Portfolio
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Shionogi & Co., Ltd.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Financial Overview
12.9.4 Product Portfolio
12.9.5 Product Pipeline
12.9.6 SWOT Analysis
12.9.7 Key Developments
12.10 Ligand Pharmaceuticals, Inc.
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Financial Overview
12.10.4 Product Portfolio
12.10.5 Product Pipeline
12.10.6 SWOT Analysis
12.10.7 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
TABLE 1. North America Narcolepsy market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 2. North America Narcolepsy market Revenue And Forecasts to 2027, By Product (US$ Mn)
TABLE 3. North America Narcolepsy market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
TABLE 4. US Narcolepsy market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 5. US Narcolepsy market Revenue And Forecasts to 2027, By Product (US$ Mn)
TABLE 6. US Narcolepsy market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
TABLE 7. Canada Narcolepsy market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 8. Canada Narcolepsy market Revenue And Forecasts to 2027, By Product (US$ Mn)
TABLE 9. Canada Narcolepsy market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
TABLE 10. Mexico Narcolepsy market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 11. Mexico Narcolepsy market Revenue And Forecasts to 2027, By Product (US$ Mn)
TABLE 12. Mexico Narcolepsy market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
TABLE 13. Europe Narcolepsy market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 14. Europe Narcolepsy market Revenue And Forecasts to 2027, By Product (US$ Mn)
TABLE 15. Europe Narcolepsy market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
TABLE 16. Germany Narcolepsy market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 17. Germany Narcolepsy market Revenue And Forecasts to 2027, By Product (US$ Mn)
TABLE 18. Germany Narcolepsy market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
TABLE 19. UK Narcolepsy market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 20. UK Narcolepsy market Revenue And Forecasts to 2027, By Product (US$ Mn)
TABLE 21. UK Narcolepsy market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
TABLE 22. France Narcolepsy market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 23. France Narcolepsy market Revenue And Forecasts to 2027, By Product (US$ Mn)
TABLE 24. France Narcolepsy market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
TABLE 25. Italy Narcolepsy market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 26. Italy Narcolepsy market Revenue And Forecasts to 2027, By Product (US$ Mn)
TABLE 27. Italy Narcolepsy market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
TABLE 28. Spain Narcolepsy market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 29. Spain Narcolepsy market Revenue And Forecasts to 2027, By Product (US$ Mn)
TABLE 30. Spain Narcolepsy market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
TABLE 31. Asia Pacific Narcolepsy market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 32. Asia Pacific Narcolepsy market Revenue And Forecasts to 2027, By Product (US$ Mn)
TABLE 33. Asia Pacific Narcolepsy market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
TABLE 34. China Narcolepsy market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 35. China Narcolepsy market Revenue And Forecasts to 2027, By Product (US$ Mn)
TABLE 36. China Narcolepsy market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
TABLE 37. Japan Narcolepsy market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 38. Japan Narcolepsy market Revenue And Forecasts to 2027, By Product (US$ Mn)
TABLE 39. Japan Narcolepsy market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
TABLE 40. India Narcolepsy market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 41. India Narcolepsy market Revenue And Forecasts to 2027, By Product (US$ Mn)
TABLE 42. India Narcolepsy market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
TABLE 43. Australia Narcolepsy market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 44. Australia Narcolepsy market Revenue And Forecasts to 2027, By Product (US$ Mn)
TABLE 45. Australia Narcolepsy market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
TABLE 46. South Korea Narcolepsy market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 47. South Korea Narcolepsy market Revenue And Forecasts to 2027, By Product (US$ Mn)
TABLE 48. South Korea Narcolepsy market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
TABLE 49. Middle East & Africa Narcolepsy market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 50. Middle East & Africa Narcolepsy market Revenue And Forecasts to 2027, By Product (US$ Mn)
TABLE 51. Middle East & Africa Narcolepsy market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
TABLE 52. UAE Narcolepsy market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 53. UAE Narcolepsy market Revenue And Forecasts to 2027, By Product (US$ Mn)
TABLE 54. UAE Narcolepsy market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
TABLE 55. SAUDI ARABIA Narcolepsy market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 56. SAUDI ARABIA Narcolepsy market Revenue And Forecasts to 2027, By Product (US$ Mn)
TABLE 57. SAUDI ARABIA Narcolepsy market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
TABLE 58. SOUTH AFRICA Narcolepsy market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 59. SOUTH AFRICA Narcolepsy market Revenue And Forecasts to 2027, By Product (US$ Mn)
TABLE 60. SOUTH AFRICA Narcolepsy market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
TABLE 61. South & Central America Narcolepsy market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 62. South & Central America Narcolepsy market Revenue And Forecasts to 2027, By Product (US$ Mn)
TABLE 63. South & Central America Narcolepsy market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
TABLE 64. BRAZIL Narcolepsy market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 65. BRAZIL Narcolepsy market Revenue And Forecasts to 2027, By Product (US$ Mn)
TABLE 66. BRAZIL Narcolepsy market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
TABLE 67. ARGENTINA Narcolepsy market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 68. ARGENTINA Narcolepsy market Revenue And Forecasts to 2027, By Product (US$ Mn)
TABLE 69. ARGENTINA Narcolepsy market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)
TABLE 70. Recent EXPANSIONS in the Narcolepsy market
TABLE 71. Recent Product Launches in the Narcolepsy market
TABLE 72. Other Organic Growth Strategies in the Narcolepsy market
TABLE 73. Recent Agreements in the Narcolepsy market
TABLE 74. Recent Acquisitions in the Narcolepsy market
TABLE 75. Recent Other Inorganic Growth Strategies in the Narcolepsy market
TABLE 76. Glossary of Terms, narcolepsy market
LIST OF FIGURES
FIGURE 1. Narcolepsy market Segmentation
FIGURE 2. bioreactors Segmentation, by region
FIGURE 3. Asia Pacific Narcolepsy market, Revenue (US$ Mn), By Geography 2018 & 2027
FIGURE 4. Global Narcolepsy market By type, Market Share (%), 2018
FIGURE 5. Global Narcolepsy market By product, Market Share (%), 2018
FIGURE 6. Global Narcolepsy market By Distribution CHannel, Market Share (%), 2018
FIGURE 7. North America PEST Analysis
FIGURE 8. Europe PEST Analysis
FIGURE 9. Asia pacific PEST Analysis
FIGURE 10. Middle East & Africa PEST Analysis
FIGURE 11. South and central america PEST Analysis
FIGURE 12. Narcolepsy market impact analysis of driver and restraints
FIGURE 13. global Narcolepsy market – Revenue Forecasts and Analysis –2018- 2027
FIGURE 14. global Narcolepsy market – by geography Forecasts and Analysis – 2018- 2027
FIGURE 15. type MARKET Analysis and Forecasts 2018 and 2027 (%)
FIGURE 16. narcolepsy with cataplexy Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 17. narcolepsy without cataplexy Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 18. secondary narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 19. product MARKET Analysis and Forecasts 2018 and 2027 (%)
FIGURE 20. central nervous system stimulants Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 21. sodium oxybate Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 22. Antidepressants Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 23. Distribution Channel MARKET Analysis and Forecasts 2018 and 2027 (%)
FIGURE 24. hospital pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 25. retail pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 26. North America Narcolepsy market revenue Overview, by Country (2017) (us $ mn)
FIGURE 27. North America Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 28. North America Narcolepsy market Revenue And Forecasts to 2027, By Country (%)
FIGURE 29. US Narcolepsy market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 30. Canada Narcolepsy market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 31. Mexico Narcolepsy market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 32. Europe Narcolepsy market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 33. Europe Narcolepsy market Revenue And Forecasts to 2027, By Country (%)
FIGURE 34. Germany Narcolepsy market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 35. UK Narcolepsy market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 36. France Narcolepsy market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 37. Italy Narcolepsy market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 38. Spain Narcolepsy market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 39. Asia Pacific Narcolepsy market revenue Overview, by Country (2018) (us $ mn)
FIGURE 40. Asia Pacific Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 41. Asia Pacific Narcolepsy market Revenue And Forecasts to 2027, By Country (%)
FIGURE 42. China Narcolepsy market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 43. Japan Narcolepsy market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 44. India Narcolepsy market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 45. Australia Narcolepsy market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 46. South Korea Narcolepsy market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 47. Middle East & Africa narcolepsy market REVENUE, by Country, 2018 (US$ MN)
FIGURE 48. Middle East & Africa Narcolepsy market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 49. Middle East & Africa Narcolepsy market Revenue And Forecasts to 2027, By Country (%)
FIGURE 50. UAE Narcolepsy market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 51. Saudi Arabia Narcolepsy market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 52. South Africa Narcolepsy market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 53. South and Central America narcolepsy market REVENUE, by Country, 2017 (US$ MN)
FIGURE 54. South and Central America Narcolepsy market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 55. South and Central America Narcolepsy market SHARE BY COUNTRY, 2017 AND 2025 (%)
FIGURE 56. Brazil narcolepsy market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 57. Argentina narcolepsy market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 58. Comparative Company Analysis
FIGURE 59. Growth Strategies in the Narcolepsy market, 2015-2018
FIGURE 60. Organic Growth Strategies in the Narcolepsy market, 2015-2018
FIGURE 61. Inorganic Growth Strategies in the Bioreactor Market, 2015-2018
The List of Companies
- Bioprojet
- Teva Pharmaceutical Industries Ltd.
- Jazz Pharmaceuticals, Inc.
- Graymark Healthcare, Inc.
- Arena Pharmaceuticals, Inc.
- Shire (Acquired by Takeda)
- Ligand Pharmaceuticals, Inc.
- Novartis AG
- Mylan N.V.
- Shionogi Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For